Skip to main content

[2020-2026] Food for Special Medical Purpose Market Size, Share, Growth, Trends, Research Analysis, Competitive Landscape, Forecast Report

Pune, Sept. 28, 2020 (GLOBE NEWSWIRE) — Increasing adoption of unhealthy lifestyles around the world is likely to be the key growth driver of the global food for special medical purpose market size in the forthcoming years. According to the World Health Organization (WHO), around 16 million disability adjusted life years (DALYs) and 2.8% of annual global deaths are caused by inadequate intake of fruits and vegetables. A sufficient consumption of fruits and vegetables prevents the risk of a vast spectrum of gastrointestinal disorders along with other chronic conditions.These numbers indicate that today people are at a much greater risk of contracting various lifestyle-related diseases and this will be one of the central food for special medical purpose market trends. Unhealthy diet regimes are compounded by a rising prevalence of smoking, especially among the working population around the world. As a result, a higher number of people are vulnerable to chronic metabolic disorders, heightening the need for FSMP products.According to the European Commission, food for special medical purpose (FSMP) are foods medically supervised and administered to individuals who are suffering certain recognized diseases or disorders. These foods are only meant for patients whose nutritional requirements cannot be met by regular food items, for example, amino acid metabolism disorder formula food for infants between the ages of 0 to 12 months.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/food-for-special-medical-purpose-fsmp-market-100320

Highlights of the Report:Analysis of the impact of Covid-19 that the market would face in the near future.In-depth analysis of the growth drivers and obstacles.Profile of all the companies operating in the market.Elaborate data about the dominating region.Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.
Increased Global Spending on Healthcare to Favor GrowthHealthcare spending has become one of the highest priorities for governments across the globe, resulting in a collective effort to elevate the health status of populations, especially in underdeveloped and developing countries. The WHO revealed that in 2016, around USD 7.5 trillion were spent on healthcare, accounting for 10% of the world GDP. It also found that total healthcare expenditure grew at a faster rate in low and middle-income countries than in developed countries.Since high cost is one of the limiting factors for FSMPs, higher government spending on such items can make them more accessible to low income groups where malnutrition has given rise to complex gastrointestinal disorders. Thus, steadily climbing public expenditure on health will bode well for the FSMP market revenue in the coming decade.The whole world is fighting the novel coronavirus. Sectors and industries are divested due to the major loss caused by COVID-19 in business. The authorities of several countries have initiated lockdown to prevent the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.
To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/food-for-special-medical-purpose-fsmp-market-100320

North America to Hold a Commanding Position; Asia-Pacific to Register Healthy GrowthNorth America is anticipated to dominate the food for special medical purpose market share mainly owing to growing prevalence of sedentary lifestyle among the people in the region. Furthermore, organizations such as the National Organization for Rare Diseases is promoting research into FSMP to meet the unusual dietary requirements of people living with severe metabolic disorders. High incidence of malnutrition in the developing nations of Asia-Pacific will be the main propeller of the FSMP market growth in the region.Product Diversification to Characterize CompetitionCompetition in this market is set to intensify on account of key players adopting strategies to strengthen their position. The prime measure undertaken by players for this purpose is the launching of new products in markets outside their territorial boundaries. This not only expands their geographical reach, but also widens their product offerings.
Key Industry Developments:July 2018: Nestlé’s PreNAN infant milk formula for low birth weight and pre-term infants was included by the State Administration for Market Regulation of China in its Food for Special Medical Purpose list.August 2017: Danone India introduced its renowned FSMP product, Neocate, in India. It is an amino acid-based formula and hypoallergenic food item to manage Cow’s Milk Allergy in young children as well as infants.  
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/food-for-special-medical-purpose-fsmp-market-100320

Prominent Players in Food for Special Medical Purpose Market:Gruppo FarmaimpresaDanone IndiaLENUS Pharma GesmbHMead Johnson & Company, LLC NestleGuangzhou New Health Biotechnology Co., LtdDarman Ara Corporation
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/food-for-special-medical-purpose-fsmp-market-100320

Food for Special Medical Purpose Market Segmentations:By Type •              Nutritionally Complete Foods•              Nutritionally Complete Foods Specific to the Disease Condition•              Nutritionally Incomplete Foods (Components)By Route of Administration             •              Oral•              Injectable•              Others.By Age Group      •              0-12 months (Infants)•              More than 1-year-oldBy End-User         •              Hospitals•              Clinics•              Ambulatory Surgical Centers•              Homecare Settings•              Others.By Geography      •              North America (USA and Canada)•              Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)•              Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)•              Latin America (Brazil, Mexico and Rest of Latin America)•              Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Have a Look at Related Reports:Nebulizer Market Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027Cystic Fibrosis Market Share & Covid-19 Impact Analysis, By Drug Class (Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), Bronchodilators, Mucolytic, Pancreatic Enzyme Supplement, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Retail Pharmacies & Drug Stores, Online Pharmacies, and Hospital Pharmacies), and Regional Forecast, 2020-2027Sleep Apnea Devices Market Share & Covid-19 Impact Analysis, By Device Type (Therapeutic Devices, and Diagnostic Devices), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2020-2027Home Infusion Therapy Market Share & Covid-19 Impact Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027Bone Void Fillers Market Share & Industry Analysis, By Type (Demineralized Bone Matrix (DBM), Collagen Matrix, Calcium Sulfate, Tri-calcium Phosphate, and Others), By Form (Gel, Granules, Paste, Putty, and Others), By End User (Hospitals, Specialty Clinics and Others), and Regional Forecast, 2020-2027About Us:Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.Contact Us:Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.